한글목차

좌골신경통 치료 시장은 2022-20271년에 30억 8,908만 달러, 예측 기간 중 CAGR은 4.83%로 성장할 것으로 예측되고 있습니다.

좌골신경통 치료 시장의 전체적인 분석, 시장 규모·예측, 동향, 시장 촉진요인·촉진요인, 과제, 약 25개 벤더를 다룬 벤더 분석 등을 제공합니다.

현재의 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공하고 있습니다. 좌골신경통에 대한 의식의 향상, 좌골신경통 위험인자의 유병률 증가, 파이프라인 의약품에 대한 규제기관 지원 등이 시장을 촉진하고 있습니다.

이 조사에서는 클로니딘 마이크로 펠릿 경막외 주입의 개발을 향후 수년간 좌골신경통 치료 시장 성장을 촉진하는 주요인의 하나로 식별하고 있습니다. 또한 좌골신경통 연구 자금의 증가 및 좌골신경통 치료의 물리치료에 대한 인식의 향상도 시장의 큰 수요로 연결될 것으로 생각됩니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 구도

• 시장 에코시스템

제3장 시장 규모

• 시장의 정의
• 시장 부문 분석
• 시장 규모 2022
• 시장 전망 2022-2027

제4장 시장 규모 실적

• 세계의 좌골신경통 치료 시장 2023-2027 2017-2021
• 최종사용자 부문 분석 2017-2021
• 제품 부문 분석 2017-2021
• 지역별 부문 분석 2017-2021
• 국가별 부문 분석 2017-2021

제5장 Five forces 분석

• Five Forces 요약
• 구매자의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁의 위협
• 시장 현황

제6장 시장 세분화 : 최종사용자별

• 시장 부문
• 비교 : 최종사용자별
• 병원 : 시장 규모와 예측 2022-2027
• 클리닉 : 시장 규모와 예측 2022-2027
• 기타 : 시장 규모와 예측 2022-2027
• 시장 기회 : 최종사용자별

제7장 시장 세분화 : 제품별

• 시장 부문
• 비교 : 제품별
• 비외과적 치료 : 시장 규모와 예측 2022-2027
• 외과적 치료 : 시장 규모와 예측 2022-2027
• 시장 기회 : 제품별

제8장 고객 상황

• 고객 상황의 개요

제9장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측 2022-2027
• 유럽 : 시장 규모와 예측 2022-2027
• 아시아 : 시장 규모와 예측 2022-2027
• 세계의 기타 지역 : 시장 규모와 예측 2022-2027
• 미국 : 시장 규모와 예측 2022-2027
• 캐나다 : 시장 규모와 예측 2022-2027
• 영국 : 시장 규모와 예측 2022-2027
• 독일 : 시장 규모와 예측 2022-2027
• 중국 : 시장 규모와 예측 2022-2027
• 시장 기회 : 지역 상황별

제10장 촉진요인, 과제 및 동향

• 시장 촉진요인
• 시장이 해결해야 할 과제
• 촉진요인과 과제의 영향
• 시장 동향

제11장 벤더 구도

• 개요
• 벤더 구도
• 혼란의 상황
• 업계의 리스크

제12장 벤더 분석

• 대상 벤더
• 벤더의 시장 포지셔닝
• Apotex Inc.
• Aurobindo Pharma Ltd.
• Bayer AG
• Dr Reddys Laboratories Ltd.
• Elam Pharma Pvt. Ltd.
• Fresenius SE and Co. KGaA
• Glenmark Pharmaceuticals Ltd.
• Hikma Pharmaceuticals Plc
• Johnson and Johnson
• Novartis AG
• Omega Laser Systems Ltd.
• Ozone Pharmaceuticals Ltd.
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.

제13장 부록

영문목차

The sciatica treatment market is forecasted to grow by USD 3089.08 mn during 2022-2027, accelerating at a CAGR of 4.83% during the forecast period. The report on the sciatica treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising awareness about sciatica, growing prevalence of risk factors for sciatica, and regulatory support for pipeline drugs.

Technavio's sciatica treatment market is segmented as below:

By End-user

• Hospital
• Clinics
• Others

By Product

• Non-surgical treatment
• Surgical treatment

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the development of clonidine micropellet epidural injections as one of the prime reasons driving the sciatica treatment market growth during the next few years. Also, increasing funds for research on sciatica and rising awareness of physiotherapy for sciatica treatment will lead to sizable demand in the market.

The report on the sciatica treatment market covers the following areas:

• Sciatica treatment market sizing
• Sciatica treatment market forecast
• Sciatica treatment market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sciatica treatment market vendors that include Amneal Pharmaceuticals Inc., Apotex Inc., Aurobindo Pharma Ltd., Bayer AG, Dr Reddys Laboratories Ltd., Elam Pharma Pvt. Ltd., Fresenius SE and Co. KGaA, Glenmark Pharmaceuticals Ltd., Hikma Pharmaceuticals Plc, Johnson and Johnson, KOLON LIFE SCIENCE, Lupin Ltd., Novartis AG, Omega Laser Systems Ltd., Ozone Pharmaceuticals Ltd., Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the sciatica treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global Sciatica Treatment Market 2023-2027 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on global sciatica treatment market 2023-2027 2017 - 2021 ($ billion)
• 4.2 End-user Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
• 4.3 Product Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by End-user

• 6.1 Market segments
• Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
• Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
• 6.2 Comparison by End-user
• Exhibit 32: Chart on Comparison by End-user
• Exhibit 33: Data Table on Comparison by End-user
• 6.3 Hospital - Market size and forecast 2022-2027
• Exhibit 34: Chart on Hospital - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Hospital - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Hospital - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Hospital - Year-over-year growth 2022-2027 (%)
• 6.4 Clinics - Market size and forecast 2022-2027
• Exhibit 38: Chart on Clinics - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Clinics - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Clinics - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Clinics - Year-over-year growth 2022-2027 (%)
• 6.5 Others - Market size and forecast 2022-2027
• Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
• 6.6 Market opportunity by End-user
• Exhibit 46: Market opportunity by End-user ($ million)
• Exhibit 47: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Product

• 7.1 Market segments
• Exhibit 48: Chart on Product - Market share 2022-2027 (%)
• Exhibit 49: Data Table on Product - Market share 2022-2027 (%)
• 7.2 Comparison by Product
• Exhibit 50: Chart on Comparison by Product
• Exhibit 51: Data Table on Comparison by Product
• 7.3 Non-surgical treatment - Market size and forecast 2022-2027
• Exhibit 52: Chart on Non-surgical treatment - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Data Table on Non-surgical treatment - Market size and forecast 2022-2027 ($ million)
• Exhibit 54: Chart on Non-surgical treatment - Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on Non-surgical treatment - Year-over-year growth 2022-2027 (%)
• 7.4 Surgical treatment - Market size and forecast 2022-2027
• Exhibit 56: Chart on Surgical treatment - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Data Table on Surgical treatment - Market size and forecast 2022-2027 ($ million)
• Exhibit 58: Chart on Surgical treatment - Year-over-year growth 2022-2027 (%)
• Exhibit 59: Data Table on Surgical treatment - Year-over-year growth 2022-2027 (%)
• 7.5 Market opportunity by Product
• Exhibit 60: Market opportunity by Product ($ million)
• Exhibit 61: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 65: Chart on Geographic comparison
• Exhibit 66: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 Canada - Market size and forecast 2022-2027
• Exhibit 87: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• 9.9 UK - Market size and forecast 2022-2027
• Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
• 9.10 Germany - Market size and forecast 2022-2027
• Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.11 China - Market size and forecast 2022-2027
• Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 103: Market opportunity By Geographical Landscape ($ million)
• Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 105: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 107: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 108: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 109: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 110: Matrix on vendor position and classification
• 12.3 Apotex Inc.
• Exhibit 111: Apotex Inc. - Overview
• Exhibit 112: Apotex Inc. - Product / Service
• Exhibit 113: Apotex Inc. - Key offerings
• 12.4 Aurobindo Pharma Ltd.
• Exhibit 114: Aurobindo Pharma Ltd. - Overview
• Exhibit 115: Aurobindo Pharma Ltd. - Product / Service
• Exhibit 116: Aurobindo Pharma Ltd. - Key offerings
• 12.5 Bayer AG
• Exhibit 117: Bayer AG - Overview
• Exhibit 118: Bayer AG - Business segments
• Exhibit 119: Bayer AG - Key news
• Exhibit 120: Bayer AG - Key offerings
• Exhibit 121: Bayer AG - Segment focus
• 12.6 Dr Reddys Laboratories Ltd.
• Exhibit 122: Dr Reddys Laboratories Ltd. - Overview
• Exhibit 123: Dr Reddys Laboratories Ltd. - Business segments
• Exhibit 124: Dr Reddys Laboratories Ltd. - Key offerings
• Exhibit 125: Dr Reddys Laboratories Ltd. - Segment focus
• 12.7 Elam Pharma Pvt. Ltd.
• Exhibit 126: Elam Pharma Pvt. Ltd. - Overview
• Exhibit 127: Elam Pharma Pvt. Ltd. - Product / Service
• Exhibit 128: Elam Pharma Pvt. Ltd. - Key offerings
• 12.8 Fresenius SE and Co. KGaA
• Exhibit 129: Fresenius SE and Co. KGaA - Overview
• Exhibit 130: Fresenius SE and Co. KGaA - Business segments
• Exhibit 131: Fresenius SE and Co. KGaA - Key news
• Exhibit 132: Fresenius SE and Co. KGaA - Key offerings
• Exhibit 133: Fresenius SE and Co. KGaA - Segment focus
• 12.9 Glenmark Pharmaceuticals Ltd.
• Exhibit 134: Glenmark Pharmaceuticals Ltd. - Overview
• Exhibit 135: Glenmark Pharmaceuticals Ltd. - Product / Service
• Exhibit 136: Glenmark Pharmaceuticals Ltd. - Key offerings
• 12.10 Hikma Pharmaceuticals Plc
• Exhibit 137: Hikma Pharmaceuticals Plc - Overview
• Exhibit 138: Hikma Pharmaceuticals Plc - Business segments
• Exhibit 139: Hikma Pharmaceuticals Plc - Key offerings
• Exhibit 140: Hikma Pharmaceuticals Plc - Segment focus
• 12.11 Johnson and Johnson
• Exhibit 141: Johnson and Johnson - Overview
• Exhibit 142: Johnson and Johnson - Business segments
• Exhibit 143: Johnson and Johnson - Key news
• Exhibit 144: Johnson and Johnson - Key offerings
• Exhibit 145: Johnson and Johnson - Segment focus
• 12.12 Novartis AG
• Exhibit 146: Novartis AG - Overview
• Exhibit 147: Novartis AG - Business segments
• Exhibit 148: Novartis AG - Key offerings
• Exhibit 149: Novartis AG - Segment focus
• 12.13 Omega Laser Systems Ltd.
• Exhibit 150: Omega Laser Systems Ltd. - Overview
• Exhibit 151: Omega Laser Systems Ltd. - Product / Service
• Exhibit 152: Omega Laser Systems Ltd. - Key offerings
• 12.14 Ozone Pharmaceuticals Ltd.
• Exhibit 153: Ozone Pharmaceuticals Ltd. - Overview
• Exhibit 154: Ozone Pharmaceuticals Ltd. - Key offerings
• 12.15 Pfizer Inc.
• Exhibit 155: Pfizer Inc. - Overview
• Exhibit 156: Pfizer Inc. - Product / Service
• Exhibit 157: Pfizer Inc. - Key news
• Exhibit 158: Pfizer Inc. - Key offerings
• 12.16 Teva Pharmaceutical Industries Ltd.
• Exhibit 159: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 160: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 161: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 162: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 163: Teva Pharmaceutical Industries Ltd. - Segment focus
• 12.17 Viatris Inc.
• Exhibit 164: Viatris Inc. - Overview
• Exhibit 165: Viatris Inc. - Business segments
• Exhibit 166: Viatris Inc. - Key news
• Exhibit 167: Viatris Inc. - Key offerings
• Exhibit 168: Viatris Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 169: Inclusions checklist
• Exhibit 170: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 171: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 172: Research methodology
• Exhibit 173: Validation techniques employed for market sizing
• Exhibit 174: Information sources
• 13.5 List of abbreviations
• Exhibit 175: List of abbreviations